Navigation Links
National Reference Laboratory, Warde Medical Laboratory to Showcase at 2013 AACC Clinical Lab Expo
Date:7/24/2013

Ann Arbor, Michigan (PRWEB) July 24, 2013

A premier national reference laboratory, Warde Medical Laboratory will showcase its comprehensive esoteric testing catalog and unique cost saving operational model in Exhibit Booth 1637 during the 2013 American Association for Clinical Chemistry in Houston, Texas.

One of the world’s largest laboratory medicine events, the event takes place at the George R. Brown Convention Center from July 28-August 1, 2013 and brings together leading industry professionals from around the globe to review the latest in scientific and clinical research, diagnostics, and laboratory management. Visit the AACC Clinical Lab Expo website for event information.

A Different Mission – a Different Model

“A different mission guides our business model,” according to Jon Sanford, Business Development Manager. “Warde was formed in 1985 for a particular purpose; to reduce the cost of laboratory testing while continuously improving the quality of healthcare. We do that in two ways. Our esoteric testing menu is designed to complement, not compete with the menus of our client hospitals and we deliberately operate with a lower profit margin.”

Additionally, not-for-profit hospitals have an opportunity to lower their costs even further by converting reference testing from an expense into an asset through a unique new co-tenancy operational model.

To find out how your hospital can lower the cost of reference testing, visit Warde Medical Laboratory in Booth 1637 at the AACC Clinical Lab Expo or us at http://www.wardelab.com.

About Warde Medical Laboratory (http://www.wardelab.com)

Warde Medical Laboratory provides comprehensive reference testing and esoteric molecular and genetic assays to for-profit and not-for-profit hospitals and multi-hospital groups across the United States. Comprehensive toxicology testing services are also available to companies and organizations for workplace drug screening and forensic testing. Warde‘s state-of-the-art-facility is staffed with highly-trained clinical specialists under the leadership of internationally-known pathologists assuring the highest levels of quality and service. Founded in 1985 with a core mission to improve the quality of healthcare, Warde Medical Laboratory deliberately operates on a lower profit margin to reduce the cost of testing. A unique operational model offers not-for-profit hospitals the opportunity to lower their costs even further.

Read the full story at http://www.prweb.com/releases/Warde/MedicalLaboratory/prweb10959138.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. National Stroke Association Teams With Clinical Trial Matching Service CureLauncher
2. Surveyed U.S. Payers Are Significantly More Likely To Reimburse Biosimilars Developed By Multinational Manufacturers Compared With Those Developed By Regional Emerging Market Players
3. Join Cornerstone Plastic Surgery for an Exclusive Evening with Internationally Reknowned New York Trained Plastic Surgeon Frederick A. Coville, MD
4. Proposals Now Being Accepted for the 2014 Pittsburgh Conference Memorial National College Grants (PCMNCG)
5. GeneCell International’s Director of Operations, Jose Cirino, Organizes A Series of Educational Seminars with South Florida's Leading Obstetricians and Gynecologist
6. Cellular Dynamics International Announces Launch of Initial Public Offering
7. New Research from SRI International Points to Biomarker that Could Track Huntingtons Disease Progression
8. Rocky Mountain Biologicals Joins International Serum Industry Association
9. DuPont Sponsors National AgriScience Ambassador Academy
10. Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013
11. RRD International Names J. Scott Tarrant President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... 11, 2017 , ... Singh Biotechnology today announced that the ... its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B VHH13 single ... the cell membrane and bind intracellular STAT3 and inhibit its function. Dysregulation of ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it ... Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):